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ARTICLE INFO abstract
Environmental factors in early life have a strong implication on the development of 
diseases in adult life. Nutritional changes during perinatal life can modify the suscepti-
bility to develop breast carcinoma. In this report, we studied the influence of a diet high 
in saturated fat in the development of breast cancer, in rats that maintained a differential 
milk intake during their lactation period. We also analysed the possible mechanisms in-
volved in tumor development. We compared mammary carcinogenesis in Sprague-Daw-
ley adult rats, grown-up in litters of 3 (L3) or 8 (L8) pups per mother during lactation to 
induce a differential consumption of maternal milk. After weaning all pups were fed with 
a diet high in saturated fat “HF” (40% of energy from lipids) until adulthood. At 55 days 
of age, the animals were treated with a single dose of dimethylbenzanthracene to study 
tumor latency, incidence and progression. Histological and immunohistochemical stud-
ies were performed. We observed that animals that maintained high milk intake (L3) had 
lower mammary cancer incidence than animals that maintained lower milk consumption 
(L8; P <0.05) when exposed to a HF diet. Tumor latency and rate of tumor growth did not 
show variations between the groups. However, the mitotic index (P< 0.05) and the ex-
pression of CD1 were significantly lower, in tumors of L3 respect to L8 (P <0.01). Animals 
with greater consumption of breast milk develop tumors that proliferate less and tend to 
have a more pronounced apoptotic process, although when maintaining a high consump-
tion of saturated fat. These results may explain, in part, the lower incidence observed in 
this group of animals. Our work reflects the importance of lactation during postnatal life 
in the prevention of breast cancer, despite other nutritional factors that may act as pro-
moters of tumor development throughout life, such as the consumption of saturated fat.
Introduction  
The understanding of the etiology of the human pathologies is 
a fundamental paradigm to investigate [1,2]. Environmental factors 
have the potential to alter the development of a young organism, 
giving rise to the physiology and metabolism of the adult who is 
thus strongly affected by the signs of early life [3]. Therefore, the 
health of an adult is shaped to a large extent from the uterus to early 
 
childhood. Obesity, diabetes, hypertension, cardiovascular diseases, 
asthma, allergies and other conditions such as cancer have origins 
in pre and early postnatal life [4]. Among the environmental factors 
to which mammals are exposed during early life, nutrition is of great 
interest; including the diet during pregnancy, the consumption of 
maternal milk during lactation, as well as the variety and quality 
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of the food received after weaning. The development programming 
from pre- and postnatal nutrition focuses on the epigenetic [5]. Milk 
is the first postnatal nutritional stimulus of all mammals since the 
beginning of extrauterine life until the end of the lactation period. It 
is a complex secretory product that represents a maternal regulator 
critical of the development of breeding [6]. 
In humans, breastfeeding provides short and long-term benefits 
for both the child and the mother [7], including the protection 
of the child against a variety of acute and chronic pathologies. 
These benefits are associated both with the amount of breast milk 
exclusively consumed, and the duration of breastfeeding. There is 
evidence that milk functions as a transmitter between the maternal 
genome of lactation and the epigenetic regulation of the genes of 
the newborn [8]. Breast cancer is one of the most common types 
of cancer and is the leading cause of cancer mortality in women 
around the world [9]. Although cancer is influenced by genetic 
conditions, there are several risk factors such as diet, overweight and 
sedentary lifestyle that could be determinants in the development 
of this disease [10]. Dietary components contribute to the etiology 
of 30-50% of all breast cancer [11,12]. In a preliminary study, we 
established an in vivo model of differential milk consumption to 
investigate the specific role of lactation in the risk of developing 
mammary carcinoma. We demonstrated that animals maintaining 
more access to maternal milk during postnatal life generate a lower 
incidence of mammary cancer in the adulthood [13]. 
Children, adolescents and young adults adopt eating patterns 
that can be the basis of their eating habits for a large part of their 
lives [14]. In this sense, there are social factors that favour a greater 
consumption of fat and its accumulation [15]. The westernized 
diet is characterized by a high content of proteins, saturated fat, 
refined grains, sugar, alcohol, salt and fructose syrup derived 
from corn, with a reduced consumption associated with fruits 
and vegetables [16]. The association between the consumption of 
fats and the development of breast cancer arose from the strong 
correlation observed in studies since 1966 [17]. The use of animal 
models demonstrated the influence of fat in the development of 
mammary tumors, independently of energy intake, which suggests 
a complex interaction between quality and quantity of dietary fat, 
obesity, inflammation, genetic background and oncogenesis [18-
22]. Studies in humans on fat consumption and development of 
breast cancer are inconsistent. This may be related to the difficulty 
to differentiate the consumption of fat with total caloric intake and 
obesity; since obesity is identified as a risk factor for breast cancer 
among postmenopausal women [23-25]. 
In this report, we studied the influence of a diet high in 
saturated fat in the development of mammary cancer, in rats that 
maintained a differential milk intake during their lactation period. 
We also analysed the possible mechanisms involved in tumor 
development. Our hypothesis is that a higher consumption of breast 
milk prevents the development of breast cancer even in animals 
that ingested a diet high in saturated fats over time. To test this 
hypothesis, we compared mammary carcinogenesis in adult rats 
grown-up in litters of 3 or 8 pups per mother during lactation, and 
that maintained a diet high in saturated fat from its weaning until 
adulthood. We found significant differences in the tumor incidence 
of the animals. In addition, we investigate the expression of some 
proteins related to mitosis in tumor cells.
Materials and Methods
Postnatal Litter Size Adjustment
Female Sprague-Dawley rats bred in our laboratory were 
used. The animals were kept in a light (lights on 6 am to 8 pm) 
and temperature (22-24 °C) controlled room. Animal maintenance 
and handling were performed according to the NIH guide for the 
Care and Use of Laboratory Animals (NIH publication no. 86-
23, revised 1991) and the UK requirements for ethics of animal 
experimentation (Animals Scientific Procedures, Act 1986). All the 
experimental procedures were approved by the Animal and Ethics 
Committee (CICUAL) of the School of Medicine of the National 
University of Cuyo, Mendoza, Argentina. One-day-old female pups 
(n = 28) born on the same day were distributed at random in litters 
of different sizes: three (L3) or eight (L8) pups per dam, to induce 
a differential consumption of maternal milk. The size of the litters 
was chosen in accordance with previous studies [13,26,27]. Body 
weight of pups was monitored every 3 days.
High Fat Diet
After weaning (at day 21), all pups were fed with a diet enriched 
in saturated fat (HF). The diet “HF” has 40% of energy from lipids 
and was prepared by adding 12.1 g of fat extracted from the first 
bovine juice per 100 g of standard food (Cargill, Argentina). In 
both groups tap water was supplied ad libitum until the end of the 
experiment. Food and beverage consumption, and body weight 
were monitored weekly, to characterize energy ingestion and 
weight gain. In this way we obtained two groups of rats’ growths 
with different levels of lactation who maintained a diet high in 
saturated fats: L3 (n = 13) and L8 (n = 15).
Food Consumption
The food was weighed and placed, on top of standard stainless-
steel cages. After 24 h the amount of remaining food was recorded, 
including any pellets at the bottom of the cages. Intake was 
calculated as the weight (in grams) of the foods provided minus 
those recovered.
Induction of Mammary Tumors
At the age of 55 days all rats were treated per os with a single 
dose (15mg / rat) of 7,12-dimethylbenzanthracene (DMBA, 
Sigma-Aldrich, USA) by an intragastric probe, 3 h after food and 
water deprivation to ensure a complete absorption of the drug. 
DMBA has been extensively used at that dose to study mammary 
carcinogenesis [28-30]. The animals were palpated twice a week. 
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Latency, incidence and progression of tumors were determined in 
all groups.
Latency, Incidence and Progression of Tumors
The latency was considered as the time between DMBA 
administration and the appearance of the first palpable tumor. 
Incidence was calculated as the percentage of rats that had tumors 
within the study period with respect to the total number of rats 
per group. We used a caliper measure the major (DM) and minor 
(dm) diameters of the tumors twice a week and calculated the 
tumor volume (TV) as TV = dm2 × DM / 2. Tumor progression was 
assessed estimating tumor growth rate (GR) as GR = TV / (day of 
sacrifice-day of appearance of first tumor).
Sample Collection
All the animals were decapitated between 10 am and 12 noon 
on the day of diestrus when the tumors reached a volume 1000 
mm3 or at the end of the experiment on day 250 if they did not 
develop any mammary tumor [13,31]. When more than one tumor 
developed in a single rat, the volume limit of 1000 mm3 was 
considered for the first tumor reaching that value. Immediately 
after decapitation, intraabdominal fat was removed, weighed and 
expressed as a percentage of total body weight. A piece of each tumor 
was removed for histopathological and immunohistochemical 
(IHC) analysis.
Immunohistochemistry
Serial sections (3-5 μm) were mounted onto 3-aminopropyl-
triethoxysilane (Sigma-Aldrich, Argentina) -coated slides for sub-
sequent IHC analysis. An antigen retrieval protocol using heat to 
unmask the antigens was used (30 min in citrate buffer, 0.01 M, pH 
6.0). Tissue sections of 9-14 tumors / group were incubated over-
night at 4 °C in humidity chambers with the primary anti-prolif-
erating cell nuclear antigen (PCNA, Dako Cytomation, Denmark), 
anti-Ki67 (Abcam, USA) and anti-cyclin D1 (CD1, Abcam, USA). A 
commercial kit to detect mouse antibody was used (Dako EnVision 
system, horseradish peroxidase, diaminobenzidine, Dako, USA). 
Slides were lightly counterstained with hematoxylin to reveal the 
nuclei, examined and photographed. The percentage of positive 
nuclei was obtained based on an average of 700 cells counted per 
sample, at 400 × magnification. We used a scoring system reported 
previously [32]. Briefly, we used an intensity score 0 = no staining, 
1 = nuclear staining of <10% of tumor cells, 2 = staining between 
11 and 33% of tumor cells, 3 = staining between 34 and 65% of 
tumor cells, 4 = staining of > 66% of tumor cells. These scores were 
obtained by two independent observers blinded on the experimen-
tal group, and a few conflicting scores were resolved by consensus.
Statistical Analysis
Values are given as means ± S.E.M. of 13–15 animals per group. 
All statistical analyses were performed using GraphPad Prism 5.01 
software (GraphPad Software Inc., USA). The data were analyzed by 
the student T test for independent samples or Mann Whitney U test 
according to the criteria of normality of the variables established 
with the Kolmogorov-Smirnov normality test. The means of the 
body weight (BW) gain of the litters in function of time were 
compared using two-way analysis of variance (ANOVA II). The 
incidence percentages were analysed by Fisher’s test. Differences 
between means were considered significant at the P < 0.05 level.
Results
Body Weight 
The growth curve of the animals with differential lactation 
shows a significant increase in weight (P <0.001) in L3 with respect 
to L8 from day 11 of life and until the end of lactation (Figure 1a). 
These results agree with those previously published [13]. This dif-
ference in weight gain is given exclusively by the consumption of 
breast milk. Figure 1b shows a greater increase in BW (P <0.05) 
in L3 with respect to L8 from weaning and up to week 15 of life 
(P <0.05), supporting that the increase in BW produced by a high 
milk consumption during lactation is maintained even during the 
post-weaning period. The consumption of a HF diet evens up the 
BW of both experimental groups after the 15th week of life and un-
til the end of the experiment (Figure 1). 
Figure  1: Pre and post-weaning BW of rats with differential milk consumption, that maintained a HF diet. 
(a) The variations in weight between the two groups can be observed from day 11 of life onward (*** P <0.001) during the 
lactation period. 
(b) The L3 pups have a greater weight with respect to the L8 pups during weeks 4 to 15 of life (* P <0.05). 
As of week, 15 of age, no differences were observed in the weights between L3 and L8. The values represent the mean ± SEM 
of 13-15 animals per group. The comparisons were made by ANOVAII.
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Food Consumption
The measurement of the intake of HF diet during the post-
weaning period (week 4 of life and until the end of the experiment) 
showed no difference between differentially breastfed animals (L3 
and L8) (Figure 2).
Intra-Abdominal Fat Mass
The intra-abdominal fat mass was extracted at the time of 
sacrifice of the animals and was expressed as a percentage of 
BW. The percentage of abdominal fat was similar among the 
experimental groups studied (Figure 3).
Figure  2: The consumption of HF diet is similar in animals with different ingestion of maternal milk. The values represent the 
mean ± SEM of 13-15 animals per group. The comparisons were made by ANOVA II.
Figure  3: The Percentage of intra-abdominal fat mass is similar in animals with HF diet and different ingestion of maternal 
milk. No differences were found in the percentage of intraabdominal fat mass between L3 and L8. The values represent the 
weight of the fatty tissue expressed as a percentage of the BW of 13-15 animals / group. The comparison was made using the 
Student’s T test for independent samples.
Mammary Carcinogenesis
We proceeded to analyse the percentage of rats that generated 
tumors within the studied period. The results obtained show that 
animals that maintained high milk intake (L3) had lower mammary 
cancer incidence than animals that maintained lower milk 
consumption (L8; P <0.05, Figure 4a) when exposed to a HF diet. On 
the other hand, tumor latency did not show variations between L3 
and L8 compared to the constant influence of a HF diet (Figure 4b). 
We also analysed the rate of tumor growth which was expressed in 
mm3 / day. Differential maternal milk intake did not significantly 
modify the growth rate of the tumors between the two groups 
(Figure 4c). That animals that maintained high milk intake (L3) had 
lower mammary cancer incidence than animals that maintained 
lower milk consumption (L8; P <0.05, Figure 4a) when exposed to 
a HF diet. 
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Figure 4: High milk intake decreases tumor incidence in a diet high in saturated fat. 
(a) The incidence of breast cancer in animals with HF diet is lower in L3 than in L8 (* P <0.05). 
(b) No differences were observed in mammary tumor latency between L3 and L8. 
(c) The rate of tumor growth was similar between L3 and L8. Values represent mean ± S.E.M. of 13-15 animals / group. 
Incidence was expressed as percentages and compared by Fisher’s test. Comparisons in latency was performed by the Student 
T test for independent samples. Tumor growth was compared by the nonparametric Mann-Whitney test. L3, litter of three pups 
per mother; L8, litter of eight pups per mother.
Tumor Proliferation
In order to evaluate the effect of fat consumption on tumor 
proliferation in animals with differential lactation, we performed 
a microscopic analysis of mitosis and apoptosis. The mitotic index 
was significantly lower (P< 0.05, Figure 5a) in L3 respect to L8. The 
apoptotic index (Figure 5b) did not show significant differences, 
however, showed a tendency to be increased in tumors of L3 
versus L8. To investigate whether the balance between mitosis 
and apoptosis influences tumor development, we calculated the 
mitotic / apoptotic ratio. This parameter tended to be increased in 
group L8 (Figure 5c). We additionally evaluated mitosis by IHC of 
PCNA, Ki67 and CD1 in the tumors. No changes were observed in 
the expression of PCNA (Figure 6a) and Ki67 (Figure 6b) between 
the groups studied. The expression of CD1 was increased in L8 with 
respect to L3 (P <0.01, Figure 6c).
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Figure 5: High milk intake decreases mitosis and tends to increase apoptosis in the tumors of animals that maintained a HF 
diet.
(a) The mitotic index was higher in tumors of L8 compared to L3 (P <0.05). 
(b) The apoptotic index tended to be increased in L3 versus L8 tumors. 
(c) The mitotic / apoptotic ratio tended to be higher in L8 when compared to L3. 
Values are means ± S.E.M. of of 8–10 fields of each preparation from 9 to 14 animals/group. Comparisons were performed by 
the non-parametric U Mann Whitney test. L3, litter of three pups per mother; L8, litter of eight pups per mother.
Figure 6: High milk intake reduces expression of CD1 in animals that maintained a diet high in saturated fat.
(a-c) Representative microphotographs (400 ×) of tumors immunoassayed to reveal PCNA, Ki67 and CD1. Histograms show 
mean ± SEM of 8-10 fields of each preparation from 9 to 14 animals / group. 
(a) PCNA-immunostaining score. The expression of PCNA determined by IHC was similar in the two groups.
(b) Ki67-immunostaining score. No differences were observed in Ki67 expression between L3 and L8. 
(c) The expression of CD1 was increased in L8 with respect to L3 (** P <0.01). 
The results were expressed as a percentage of CD1 positive cells. Comparisons were performed by the nonparametric U Mann 
Whitney test for PCNA and Ki67 and the Student T test for independent samples for CD1.
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Discussion
Environmental factors in early life have a strong implication on 
the development of diseases in adult life. Epidemiological studies in 
humans and research in animal models have shown that nutritional 
changes during early life can modify the susceptibility to develop 
breast carcinoma [3]. The mechanisms by which early nutrition can 
induce stable physiological or metabolic changes involve epigenetic 
processes capable of altering gene expression [3,33]. In this sense, 
feeding during childhood and preadolescence can affect growth 
and development parameters of adolescents, such as the age at first 
menarche, and the age and amplitude of the peak of growth. Each of 
these parameters act independently as risk factors associated with 
the development of breast cancer [34]. The peak height growth 
velocity has been positively associated with breast cancer risk [35]. 
Whereas, breast cancer risk increased for every year at menarche 
[36]. While the evidence from the studies regarding the association 
of total and subtypes of fat intake with breast cancer risk are 
inconsistent, several studies have shown that saturated fat intake is 
associated with an increased risk of breast cancer. 
The Women’s Health Initiative study found a tendency to 
reduce the risk of breast cancer in post-menopausal women who 
maintained a low-fat diet [37]. Accordingly, diets high in saturated 
fat were associated with an increased risk of developing estrogen 
receptor positive breast cancer [38]. Several case-control studies 
have found a positive association between the consumption of 
saturated fats and the risk of developing breast cancer [39-42]. 
On the other hand, a meta-analysis of 11 cohort studies found no 
association between saturated fat intake and breast cancer [43]. 
In a preliminary study we demonstrated that animals maintaining 
more access to maternal milk during postnatal life showed a lower 
incidence of mammary cancer in the adulthood [13]. This work 
allowed us to identify the effect over time of variations in postnatal 
maternal milk consumption, with a controlled animal model. We 
know that, extrapolated to humans, the benefits of breast milk 
consumption can be influenced by a number of other nutritional 
factors after weaning. To have a more complete knowledge on 
the subject, we wanted to study the influence of a diet with a 
high content of saturated fat (simulating a Western diet) from the 
moment of weaning in those animals that had consumed different 
amounts of breast milk during their lactation. 
This allowed us to get closer to the complex food interaction 
that the human being experiences in critical periods of its 
development. We observed that the greater consumption of breast 
milk during postnatal life prevents the development of breast 
cancer, even when a high intake of saturated fat is maintained over 
time. This suggests that a greater consumption of breast milk can 
activate epigenetic, physiological and / or metabolic changes that 
decrease the susceptibility of the mammary gland to the cancerous 
development even in the presence of promoter stimulus such as 
the high-fat diet. The development and progression of cancer is 
strongly influenced by the proliferation process. This is manifested 
by altered expression and / or activity of cell cycle related proteins 
[44]. In the present study, we analysed cell proliferation through 
the mitosis count and the detection by immunohistochemical 
staining of cell cycle proteins [45]. We observed that L8 animals 
had more proliferative tumors compared to L3, evidenced by the 
greater number of mitotic bodies and the greater expression of CD1 
observed in the tumor sections. This suggests that animals with 
greater consumption of breast milk develop tumors that proliferate 
less and tend to have a more pronounced apoptotic process, 
although when maintaining a high consumption of saturated fat. 
These results may explain, in part, the lower incidence 
observed in this group of animals. Although the animals with the 
highest consumption of breast milk developed less proliferative 
tumors, no differences were observed in the tumor growth rate. 
Our work reflects the importance of lactation during postnatal life 
in the prevention of breast cancer, despite other nutritional factors 
that may act as promoters of tumor development throughout life, 
such as the consumption of saturated fat. The animal model used 
allowed us to study in depth the influence of different consumption 
of breast milk, and the influence of the ingestion of a high-fat diet 
simulating a western style of feeding. It is necessary to delve into 
the possible mechanisms involved by the components of breast milk 
on the development of mammary epithelium and carcinogenesis. It 
is of great interest to detect altered epigenetic marks in early life 
that can provide biomarkers to detect individuals at higher risk of 
disease.
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